DMARDs likely to dominate the therapy market for Rheumatoid Arthritis – Frost and Sullivan
In spite of new drugs available for treating Rheumatoid Arthritis, DMARDs are likely to remain as the preferred first line of therapy.
Say something
-
-
Flipkart Health+ App Launched
06-04-2022
